These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36526430)

  • 1. Blood Pressure and Risk of Dementia in Parkinson Disease and Multiple System Atrophy: Should You Buy the Dip in Such a Volatile Market?
    Palma JA; Cortelli P
    Neurology; 2023 Mar; 100(10):451-453. PubMed ID: 36526430
    [No Abstract]   [Full Text] [Related]  

  • 2. Is pure autonomic failure an early marker for Parkinson disease, dementia with Lewy bodies, and multiple system atrophy? And other updates on recent autonomic research.
    Muppidi S; Miglis MG
    Clin Auton Res; 2017 Apr; 27(2):71-73. PubMed ID: 28255741
    [No Abstract]   [Full Text] [Related]  

  • 3. REM sleep behavior in Parkinson disease: Frequent, particularly with higher age.
    Baumann-Vogel H; Hor H; Poryazova R; Valko P; Werth E; Baumann CR
    PLoS One; 2020; 15(12):e0243454. PubMed ID: 33284860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autonomic dysfunction in dementia with Lewy bodies.
    Thaisetthawatkul P; Boeve BF; Benarroch EE; Sandroni P; Ferman TJ; Petersen R; Low PA
    Neurology; 2004 May; 62(10):1804-9. PubMed ID: 15159482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin in synucleinopathies.
    Hsam O; Kohl Z
    Behav Brain Res; 2023 May; 445():114367. PubMed ID: 36863462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognizing Atypical Parkinsonisms: "Red Flags" and Therapeutic Approaches.
    McFarland NR; Hess CW
    Semin Neurol; 2017 Apr; 37(2):215-227. PubMed ID: 28511262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival and Causes of Death Among People With Clinically Diagnosed Synucleinopathies With Parkinsonism: A Population-Based Study.
    Savica R; Grossardt BR; Bower JH; Ahlskog JE; Boeve BF; Graff-Radford J; Rocca WA; Mielke MM
    JAMA Neurol; 2017 Jul; 74(7):839-846. PubMed ID: 28505261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. REM sleep behavior disorder and the risk of developing Parkinson disease or dementia.
    Britton TC; Chaudhuri KR
    Neurology; 2009 Apr; 72(15):1294-5. PubMed ID: 19164135
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.
    Brenner SR
    Neurology; 2008 Jun; 70(23):2265; author reply 2265. PubMed ID: 18519878
    [No Abstract]   [Full Text] [Related]  

  • 10. Parkinson Disease and Dementia.
    Garcia-Ptacek S; Kramberger MG
    J Geriatr Psychiatry Neurol; 2016 Sep; 29(5):261-70. PubMed ID: 27502301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
    Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
    Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comment: epidemiology of dementia with Lewy bodies--the Alzheimer-Parkinson overlap.
    Postuma RB
    Neurology; 2013 Aug; 81(9):838. PubMed ID: 23892703
    [No Abstract]   [Full Text] [Related]  

  • 13. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.
    Beyer MK; Larsen JP; Aarsland D
    Neurology; 2007 Aug; 69(8):747-54. PubMed ID: 17709706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality-of-life and burden for caregivers of individuals with neurogenic orthostatic hypotension.
    Gallop K; Pham N; Maclaine G; Saunders E; Black B; Hubig L; Acaster S
    Neurodegener Dis Manag; 2023 Feb; 13(1):35-45. PubMed ID: 36382590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myoclonus in parkinsonian disorders.
    Shafiq M; Lang AE
    Adv Neurol; 2002; 89():77-83. PubMed ID: 11968474
    [No Abstract]   [Full Text] [Related]  

  • 16. α-Synuclein pathology accumulates in sacral spinal visceral sensory pathways.
    VanderHorst VG; Samardzic T; Saper CB; Anderson MP; Nag S; Schneider JA; Bennett DA; Buchman AS
    Ann Neurol; 2015 Jul; 78(1):142-9. PubMed ID: 25893830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy of Parkinson disease dementia and Lewy body dementia.
    Gauthier S
    Front Neurol Neurosci; 2009; 24():135-139. PubMed ID: 19182471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [REM Sleep Behavior Disorder and α-synucleinopathy].
    Miyamoto T; Numahata K; Ishido H; Miyamoto M
    Brain Nerve; 2020 Feb; 72(2):107-117. PubMed ID: 32036336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for dementia with Lewy bodies: a case-control study.
    Golimstok A
    Neurology; 2014 Apr; 82(15):1384-5. PubMed ID: 24733859
    [No Abstract]   [Full Text] [Related]  

  • 20. Cognitive disturbances in Parkinson's disease.
    Grujic Z
    Dis Mon; 2007 May; 53(5):302-8. PubMed ID: 17656192
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.